Cargando…
Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019
Noncholera vibriosis is a rare, opportunistic bacterial infection caused by Vibrio spp. other than V. cholerae O1/O139 and diagnosed mainly during the hot summer months in patients after seaside activities. Detailed knowledge of circulating pathogenic strains and heterogeneities in infection outcome...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707594/ https://www.ncbi.nlm.nih.gov/pubmed/36418019 http://dx.doi.org/10.3201/eid2812.220748 |
_version_ | 1784840734522736640 |
---|---|
author | Hoefler, Florence Pouget-Abadie, Xavier Roncato-Saberan, Mariam Lemarié, Romain Takoudju, Eve-Marie Raffi, François Corvec, Stéphane Le Bras, Morgane Cazanave, Charles Lehours, Philippe Guimard, Thomas Allix-Béguec, Caroline |
author_facet | Hoefler, Florence Pouget-Abadie, Xavier Roncato-Saberan, Mariam Lemarié, Romain Takoudju, Eve-Marie Raffi, François Corvec, Stéphane Le Bras, Morgane Cazanave, Charles Lehours, Philippe Guimard, Thomas Allix-Béguec, Caroline |
author_sort | Hoefler, Florence |
collection | PubMed |
description | Noncholera vibriosis is a rare, opportunistic bacterial infection caused by Vibrio spp. other than V. cholerae O1/O139 and diagnosed mainly during the hot summer months in patients after seaside activities. Detailed knowledge of circulating pathogenic strains and heterogeneities in infection outcomes and disease dynamics may help in patient management. We conducted a multicenter case-series study documenting Vibrio infections in 67 patients from 8 hospitals in the Bay of Biscay, France, over a 19-year period. Infections were mainly caused by V. alginolyticus (34%), V. parahaemolyticus (30%), non-O1/O139 V. cholerae (15%), and V. vulnificus (10%). Drug-susceptibility testing revealed intermediate and resistant strains to penicillins and first-generation cephalosporins. The acute infections (e.g., those involving digestive disorder, cellulitis, osteitis, pneumonia, and endocarditis) led to a life-threatening event (septic shock), amputation, or death in 36% of patients. Physicians may need to add vibriosis to their list of infections to assess in patients with associated risk factors. |
format | Online Article Text |
id | pubmed-9707594 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-97075942022-12-09 Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019 Hoefler, Florence Pouget-Abadie, Xavier Roncato-Saberan, Mariam Lemarié, Romain Takoudju, Eve-Marie Raffi, François Corvec, Stéphane Le Bras, Morgane Cazanave, Charles Lehours, Philippe Guimard, Thomas Allix-Béguec, Caroline Emerg Infect Dis Synopsis Noncholera vibriosis is a rare, opportunistic bacterial infection caused by Vibrio spp. other than V. cholerae O1/O139 and diagnosed mainly during the hot summer months in patients after seaside activities. Detailed knowledge of circulating pathogenic strains and heterogeneities in infection outcomes and disease dynamics may help in patient management. We conducted a multicenter case-series study documenting Vibrio infections in 67 patients from 8 hospitals in the Bay of Biscay, France, over a 19-year period. Infections were mainly caused by V. alginolyticus (34%), V. parahaemolyticus (30%), non-O1/O139 V. cholerae (15%), and V. vulnificus (10%). Drug-susceptibility testing revealed intermediate and resistant strains to penicillins and first-generation cephalosporins. The acute infections (e.g., those involving digestive disorder, cellulitis, osteitis, pneumonia, and endocarditis) led to a life-threatening event (septic shock), amputation, or death in 36% of patients. Physicians may need to add vibriosis to their list of infections to assess in patients with associated risk factors. Centers for Disease Control and Prevention 2022-12 /pmc/articles/PMC9707594/ /pubmed/36418019 http://dx.doi.org/10.3201/eid2812.220748 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Synopsis Hoefler, Florence Pouget-Abadie, Xavier Roncato-Saberan, Mariam Lemarié, Romain Takoudju, Eve-Marie Raffi, François Corvec, Stéphane Le Bras, Morgane Cazanave, Charles Lehours, Philippe Guimard, Thomas Allix-Béguec, Caroline Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019 |
title | Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019 |
title_full | Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019 |
title_fullStr | Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019 |
title_full_unstemmed | Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019 |
title_short | Clinical and Epidemiologic Characteristics and Therapeutic Management of Patients with Vibrio Infections, Bay of Biscay, France, 2001–2019 |
title_sort | clinical and epidemiologic characteristics and therapeutic management of patients with vibrio infections, bay of biscay, france, 2001–2019 |
topic | Synopsis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707594/ https://www.ncbi.nlm.nih.gov/pubmed/36418019 http://dx.doi.org/10.3201/eid2812.220748 |
work_keys_str_mv | AT hoeflerflorence clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019 AT pougetabadiexavier clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019 AT roncatosaberanmariam clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019 AT lemarieromain clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019 AT takoudjuevemarie clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019 AT raffifrancois clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019 AT corvecstephane clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019 AT lebrasmorgane clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019 AT cazanavecharles clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019 AT lehoursphilippe clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019 AT guimardthomas clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019 AT allixbegueccaroline clinicalandepidemiologiccharacteristicsandtherapeuticmanagementofpatientswithvibrioinfectionsbayofbiscayfrance20012019 |